NASDAQ:PRVB
Provention Bio, Inc.
- Stock
Last Close
24.98
26/04 20:00
Market Cap
2.38B
Beta: 2.46
Volume Today
9.12M
Avg: 2.81M
PE Ratio
−16.52
PFCF: −31.17
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|
net income | -9.13M - | -26.48M 189.91% | -43.28M 63.48% | -98.58M 127.75% | -114.43M 16.08% | -113.56M 0.76% | |
depreciation and amortization | -16K - | 33K 306.25% | 387K 1,072.73% | 1.23M 217.31% | |||
deferred income tax | 16K - | 247K 1,443.75% | 538K 117.81% | ||||
stock based compensation | 206.72K - | 1.14M 451.95% | 2.84M 149.08% | 13.22M 365.27% | 11.84M 10.47% | 19.03M 60.72% | |
change in working capital | 519.86K - | -1.80M 446.83% | 4.39M 343.70% | 8.72M 98.38% | 6.32M 27.50% | 17.94M 183.81% | |
accounts receivables | -1.36M - | ||||||
inventory | -1.23M - | ||||||
accounts payables | 459.75K - | 109K 76.29% | 1.21M 1,007.34% | 5.79M 379.95% | -4.02M 169.43% | 3.21M 179.94% | |
other working capital | 60.11K - | -1.91M 3,280.89% | 3.19M 266.68% | 2.92M 8.25% | 10.34M 253.69% | 17.31M 67.40% | |
other non cash items | 3.52M - | 4.50M 27.60% | -16K 100.36% | 25K 256.25% | -37K 248% | -36K 2.70% | |
net cash provided by operating activities | -4.88M - | -22.64M 363.81% | -36.06M 59.28% | -76.34M 111.66% | -95.39M 24.95% | -75.41M 20.94% | |
investments in property plant and equipment | -1.11M - | -961K 13.50% | -795K 17.27% | ||||
acquisitions net | |||||||
purchases of investments | -46.25M - | -28.71M 37.91% | -55.28M 92.53% | -103.08M 86.46% | |||
sales maturities of investments | 55M - | 25.15M 54.27% | 30.75M 22.27% | ||||
other investing activites | -15M - | ||||||
net cash used for investing activites | -46.25M - | 25.17M 154.43% | -31.10M 223.52% | -88.13M 183.40% | |||
debt repayment | |||||||
common stock issued | 1K - | 59.35M 5,934,600% | 62.94M 6.06% | 113.14M 79.75% | 102.33M 9.55% | 104.64M 2.26% | |
common stock repurchased | |||||||
dividends paid | |||||||
other financing activites | 26.71M - | 1.15M - | 48K 95.83% | 24.75M 51,452.08% | |||
net cash used provided by financing activities | 26.72M - | 59.35M 122.14% | 62.94M 6.06% | 114.29M 81.58% | 102.38M 10.42% | 129.38M 26.38% | |
effect of forex changes on cash | |||||||
net change in cash | 21.83M - | 36.70M 68.11% | -19.37M 152.78% | 63.13M 425.84% | -24.10M 138.18% | -34.15M 41.68% | |
cash at beginning of period | 21.83M - | 58.54M 168.11% | 39.16M 33.10% | 102.29M 161.19% | 78.19M 23.56% | ||
cash at end of period | 21.83M - | 58.54M 168.11% | 39.16M 33.10% | 102.29M 161.19% | 78.19M 23.56% | 44.04M 43.68% | |
operating cash flow | -4.88M - | -22.64M 363.81% | -36.06M 59.28% | -76.34M 111.66% | -95.39M 24.95% | -75.41M 20.94% | |
capital expenditure | -1.11M - | -961K 13.50% | -795K 17.27% | ||||
free cash flow | -4.88M - | -22.64M 363.81% | -36.06M 59.28% | -77.45M 114.74% | -96.35M 24.40% | -76.20M 20.91% |
All numbers in USD (except ratios and percentages)